Natixis Advisors LLC decreased its holdings in Cognex Co. (NASDAQ:CGNX - Free Report) by 26.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,703 shares of the scientific and technical instruments company's stock after selling 16,581 shares during the quarter. Natixis Advisors LLC's holdings in Cognex were worth $1,639,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. State Street Corp grew its stake in shares of Cognex by 0.8% in the 3rd quarter. State Street Corp now owns 5,190,365 shares of the scientific and technical instruments company's stock valued at $210,210,000 after purchasing an additional 42,882 shares during the last quarter. Disciplined Growth Investors Inc. MN grew its position in Cognex by 8.9% in the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 3,751,807 shares of the scientific and technical instruments company's stock valued at $151,948,000 after buying an additional 305,913 shares during the last quarter. Geode Capital Management LLC grew its position in Cognex by 5.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,608,028 shares of the scientific and technical instruments company's stock valued at $146,157,000 after buying an additional 175,423 shares during the last quarter. Point72 Asset Management L.P. raised its position in Cognex by 122.7% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,834,755 shares of the scientific and technical instruments company's stock worth $114,808,000 after buying an additional 1,562,115 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Cognex in the 4th quarter worth $79,797,000. Hedge funds and other institutional investors own 88.12% of the company's stock.
Cognex Stock Performance
NASDAQ:CGNX traded down $0.73 during mid-day trading on Friday, hitting $30.01. 1,198,501 shares of the company's stock traded hands, compared to its average volume of 1,251,266. Cognex Co. has a 1 year low of $29.59 and a 1 year high of $53.13. The company has a market cap of $5.08 billion, a PE ratio of 49.20 and a beta of 1.43. The firm's 50 day simple moving average is $35.04 and its 200 day simple moving average is $37.56.
Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The scientific and technical instruments company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.01). Cognex had a return on equity of 5.65% and a net margin of 11.61%. On average, research analysts expect that Cognex Co. will post 0.61 earnings per share for the current fiscal year.
Cognex Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Thursday, February 27th were paid a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date of this dividend was Thursday, February 27th. Cognex's payout ratio is currently 52.46%.
Analyst Ratings Changes
A number of brokerages have recently issued reports on CGNX. Cantor Fitzgerald upgraded shares of Cognex to a "strong-buy" rating in a research note on Friday, December 20th. Needham & Company LLC cut their target price on Cognex from $47.00 to $41.00 and set a "buy" rating for the company in a research note on Friday, February 14th. Truist Financial reissued a "hold" rating and issued a $37.00 price target (down from $43.00) on shares of Cognex in a report on Friday, February 14th. Stephens reaffirmed an "overweight" rating and set a $55.00 price objective on shares of Cognex in a report on Wednesday, March 12th. Finally, The Goldman Sachs Group reduced their target price on Cognex from $39.00 to $35.00 and set a "sell" rating for the company in a report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $44.83.
Check Out Our Latest Stock Analysis on Cognex
Insider Buying and Selling
In other Cognex news, EVP Carl Gerst sold 6,803 shares of the firm's stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $32.73, for a total transaction of $222,662.19. Following the sale, the executive vice president now directly owns 4,566 shares of the company's stock, valued at $149,445.18. This trade represents a 59.84 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.60% of the stock is currently owned by company insiders.
About Cognex
(
Free Report)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Featured Articles
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
